Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2005

01-08-2005

Preoperative Chemoradiotherapy (Modified Eilber Protocol) Provides Maximum Local Control and Minimal Morbidity in Patients With Soft Tissue Sarcoma

Authors: Lloyd A. Mack, MD, Phil J. Crowe, MD, Jia Lin Yang, MEd, PhD, Norman S. Schachar, MD, Don G. Morris, MD, PhD, Elizabeth C. Kurien, MD, Claire L. F. Temple, MD, Robert L. Lindsay, MD, Enzio Magi, MD, William G. DeHaas, MD, Walley J. Temple, MD, FRCSC, FACS

Published in: Annals of Surgical Oncology | Issue 8/2005

Login to get access

Abstract

Background

Local recurrence rates of 15% to 30% after treatment of soft tissue sarcoma (STS) are still common but unacceptable. Our hypothesis was that a refined neoadjuvant chemotherapy and radiation protocol (modified Eilber protocol) improves local control rates while minimizing major morbidity.

Methods

Consecutive patients with STS deep to the fascia of the extremity or trunk during 1984 to 1996 were treated with 3 days of doxorubicin (30 mg/day) and sequential radiation (300 cGy/day for 10 days). Wide excision with limb preservation was performed 4 to 8 weeks after radiation completion. Treatment complications, margins, local recurrence, and survival were prospectively documented.

Results

Of 75 patients, 66% had tumors >5 cm, and 71% were grade 2/3. In eight patients, negative margins were not achieved, and four of these had amputation (95% limb salvage). Three of the remaining four had local recurrence with a 5- and 7-year actuarial local control rate of 50% and 25%, respectively. In contrast, of the 67 patients with negative margins, a local control rate of 97% at 5 years and 94% at 7 years and an overall survival of 63% were achieved. Although margin (P = .001) and stage (P = .035) were correlated, these were not significant on multivariate Cox regression analysis. Risk factors for death included tumor stage (hazard ratio, 1.54; P = .001) and tumor grade (hazard ratio, 1.4; P = .02). Three patients (4%) required reoperation for tissue loss, and eight patients (10.6%) developed minor wound complications.

Conclusions

This modified Eilber protocol seems to maximize local control and minimize major wound complications for extremity/truncal STS.
Literature
1.
Eilber FR, Mirra JJ, Grant TT, Weisenburger T, Morton DL. Is amputation necessary for sarcomas? Ann Surg 1980;192:431–8
2.
Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305–15
3.
Pisters PWT, Leung DHY, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679–89
4.
Coindre J, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14:869–77
5.
Trovik CS, Bauer HCR, Berlin O, et al. Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Ortop Scand 2001;72:160–6
6.
Fabrizio PL, Stafford SL, Pritchard DJ. Extremity soft-tissue sarcomas selectively treated with surgery alone. Int J Radiat Oncol Biol Phys 2000;48:227–32
7.
Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197–203
8.
Zagars GK, Ballo MT, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003;97:2530–43
9.
Temple WJ, Temple CLF, Arthur KA, Schachar NS, Paterson AHG, Crabtree TS. Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas. Ann Surg Oncol 1997;4:586–90
10.
Coindre J, Bui NB, Bonichon F, De Mascarel I, Trojani M. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988;61:2305–9
11.
Brennan MF. Staging of soft tissue sarcomas. Ann Surg Oncol 1999;6:8–9
12.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81
13.
Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187–220
14.
Pollack A, Zagars GK, Goswitz MS, Pollock RE, Feig BW, Pisters PWT. Preoperative vs. postoperative radiotherapy in the treatment of primary soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1998;42:563–72
15.
Suit HD, Mankin HJ, Wood WC, Proppe KH. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 1985;55:2659–67
16.
O’Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235–41
17.
Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 2003;237:218–26
18.
Eilber FC, Rosen G, Eckardt J, et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001;19:3203–9
19.
Eilber F, Eckardt J, Rosen G, Forscher C, Fu Y. Preoperative therapy for soft tissue sarcoma. Hematol Oncol Clin North Am 1995;9:817–23
20.
Mollabashy A, Virkus WW, Zlotecki RA, Berry BH, Scarborough MT. Radiation therapy for low-grade soft tissue sarcoma. Clin Orthop Res 2002;397:190–5
21.
Baldini EH, Goldberg J, Jenner C, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 1999;17:3252–9
22.
Rydholm A, Gustafson P, Rooser B, et al. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991;9:1757–65
23.
Popov P, Tukiainen E, Asko-Seljaavaara S, et al. Soft tissue sarcomas of the lower extremity: surgical treatment and outcome. Eur J Surg Oncol 2000;26:679–85
24.
Nielsen OS, Cummings B, O’Sullivan B, Catton C, Bell RS, Fornasier VI. Preoperative and postoperative irradiation of soft tissue sarcomas: effect of radiation field size. Int J Radiat Oncol Biol Phys 1991;21:1595–9
25.
Eilber FC, Eckardt JJ, Rosen G, Nelson SD, Selch M, Eilber FR. Large, deep, high-grade extremity sarcomas: treating tumors of the flexor fossae. Surg Oncol 1999;8:211–4
26.
Davis AM, O’Sullivan B, Bell RS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2002;20:4472–7
27.
Pisters PWT. Chemoradiation treatment strategies for localized sarcoma: conventional and investigation approaches. Semin Surg Oncol 1999;17:66–71
28.
Eilber FR, Giuliano AE, Huth JF, Weisenburger TH, Eckardt J. Intravenous (IV) vs. intraarterial (IA) Adriamycin, 2800r radiation and surgical excision for extremity soft tissue sarcomas: a randomized prospective trial Proc Am Soc Clin Oncol 1990;9:309. (abstract)
29.
Pisters PWT, Harrison LB, Leung DHY, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859–68
30.
Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993;27:259–65
31.
Mack LA, Temple WJ, DeHaas WG, Schachar NS, Morris DG, Kurien E. Groin soft tissue tumors—a challenge for local control and reconstruction: a prospective cohort analysis. J Surg Oncol 2004;86:147–51
Metadata
Title
Preoperative Chemoradiotherapy (Modified Eilber Protocol) Provides Maximum Local Control and Minimal Morbidity in Patients With Soft Tissue Sarcoma
Authors
Lloyd A. Mack, MD
Phil J. Crowe, MD
Jia Lin Yang, MEd, PhD
Norman S. Schachar, MD
Don G. Morris, MD, PhD
Elizabeth C. Kurien, MD
Claire L. F. Temple, MD
Robert L. Lindsay, MD
Enzio Magi, MD
William G. DeHaas, MD
Walley J. Temple, MD, FRCSC, FACS
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2005.03.064

Other articles of this Issue 8/2005

Annals of Surgical Oncology 8/2005 Go to the issue

OriginalPaper

Efficacy of Repeat Isolated Limb Perfusions With Tumor Necrosis Factor α and Melphalan for Multiple In-Transit Metastases in Patients with Prior Isolated Limb Perfusion Failure

Editorial

Preoperative Multimodality Treatment of Localized Soft Tissue Sarcoma: Addition Through Subtraction?

OriginalPaper

Predictors and Natural History of In-Transit Melanoma After Sentinel Lymphadenectomy

OriginalPaper

A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma

OriginalPaper

Predicting Biopsy Outcome After Mammography: What Is the Likelihood the Patient Has Invasive or In Situ Breast Cancer?

Editorial

What Is the Best Treatment for Stage IV Colorectal Cancer?